ClinicalTrials.govpublic full text
Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases
liver only metastasis from kras exon 2 wild type (under protocol 1.0-1.2 edition) and ras wild type (under protocol 2.0 edition) colorectal cancer, bevacizumab, cetuximab, kras wild type colorectal cancer, ras wild type colorectal cancer, liver metastasis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 994498
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.